Suggested remit: To appraise the clinical and cost effectiveness of OrganOx metra within its CE mark for preserving donor livers for transplant.
Topic included as part of HTE10066
- Status:
- Discontinued
- Technology type:
- Device
- Decision:
- Selected
- Reason for decision:
- Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in use addressed, and help them make the best use of NHS resources
- Process:
- TA
- ID number:
- 5116
Project Team
- Project lead
- Lee Berry
Email enquiries
If you have any queries please email Lee.Berry@nice.org.uk
Timeline
Key events during the development of the guidance:
| Date | Update |
|---|---|
| 01 July 2025 | Discontinued. Topic included as part of HTE10066 |
| 01 July 2025 | This topic has been discontinued as the technology in included in HTE10066 https://www.nice.org.uk/guidance/indevelopment/gid-hte10066 |
| 05 October 2022 | Invitation to participate |
| 17 August 2022 (10:00) | Scoping workshop |
| 06 July 2022 - 03 August 2022 | Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators |
| 06 July 2022 | In progress. Scoping commenced |
| 16 May 2022 | • The topic was discussed at the Topic Selection Oversight Panel (TSOP) in March 2022. The panel concluded that the topic was suitable for a Technology Appraisal. Should the device receive positive NICE guidance as a TA and recommended for use, the recommendations set out in the NICE regulations section 7, will apply. |
| 11 May 2022 | Awaiting development |
For further information on our processes and methods, please see our CHTE processes and methods manual